Abiomed
ABMD
#1087
Rank
HK$133.27 B
Marketcap
HK$2,956
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): HK$46.07

According to Abiomed's latest financial reports the company's current EPS (TTM) is HK$45.61. In 2021 the company made an earnings per share (EPS) of HK$22.73 a decrease over its 2020 EPS that were of HK$34.52.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)HK$46.07102.68%
2021HK$22.73-34.16%
2020HK$34.52-18.05%
2019HK$42.129.48%
2018HK$38.48141.95%
2017HK$15.9081.42%
2016HK$8.77-62.83%
2015HK$23.58575.56%
2014HK$3.49125%
2013HK$1.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$66.71 46.26%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.36-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$4.19-109.18%๐Ÿ‡บ๐Ÿ‡ธ USA